Organon
Industry
- Pharmaceuticals
- Vaccines
- Specialty Pharmaceuticals
- Biotechnology
Other Names/Subsidiaries
- Alydia Health
- Dermavant Sciences
- Forendo Pharma
- Forendo Pharma Oy
- Organon & Co.
- Organon NV
Latest on Organon
Last week’s J.P. Morgan Healthcare Conference in San Francisco generated multiple headlines for the generics and biosimilars industry, with Generics Bulletin bringing you dedicated stories on the la
Many of China’s homegrown first-in-class drugs have had a hard time becoming rainmakers for their originators, with few becoming blockbusters in domestic or international sales terms. Since the first
In March 2025, the US biosimilars market will celebrate ten years since the first biosimilar received approval from the US Food and Drug Administration, under the Biologics Price Competition and Innov
Organon’s results for the third quarter of 2024 were in line with the expectations of industry analysts, on the back of a consistent performance with some mixed signals and questions surrounding futur